Browsing Tag
Alzheimer’s Association International Conference
3 posts
Why CGTX stock could draw attention after FDA alignment on DLB psychosis
Cognition Therapeutics’ FDA alignment gives zervimesine a clearer DLB psychosis path, sharpening CGTX’s dementia drug development and stock story.
Spear Bio unveils SPEAR UltraDetect, a new ultrasensitive immunoassay platform targeting neurology biomarkers
Spear Bio launches SPEAR UltraDetect, an ultrasensitive immunoassay platform enabling precise neurology biomarker detection in blood; Bio-Techne to distribute globally.
Say goodbye to brain scans! How blood tests are set to revolutionize Alzheimer’s detection
A groundbreaking study by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has revealed that…